+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Pharmakokinetic studies show decreased absorption of oral methylprednisolone compared with intravenous methylprednisolone in rheumatic disease patients with active vasculitis



Pharmakokinetic studies show decreased absorption of oral methylprednisolone compared with intravenous methylprednisolone in rheumatic disease patients with active vasculitis



Pediatric Research 47(4 Part 2): 16A




(PDF emailed within 1 workday: $29.90)

Accession: 035489178

Download citation: RISBibTeXText


Related references

High dose intravenous methylprednisolone "pulse" therapy in patients with rheumatoid disease. Plasma methylprednisolone levels and adrenal function. European Journal of Clinical Pharmacology 21(5): 385-388, 1982

Comparative pharmacokinetics of methylprednisolone mp and its prodrugs following intravenous doses of methylprednisolone sodium succinate mpss and methylprednisolone suleptanate mpsp in humans. Clinical Pharmacology & Therapeutics 43(2): 189, 1988

Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. International Journal of Clinical Practice 61(1): 45-51, 2006

Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. Arthritis and Rheumatism 59(2): 222-226, 2008

Pilot study of the pharmacokinetics of methylprednisolone after single and multiple intravenous doses of methylprednisolone sodium succinate and methylprednisolone suleptanate to healthy volunteers. Journal of Clinical Pharmacology 34(11): 1109-1115, 1994

Severe immunoglobulin E-mediated anaphylaxis to intravenous methylprednisolone succinate in a patient who tolerated oral methylprednisolone. Journal of Investigational Allergology and Clinical Immunology 19(4): 330-332, 2009

A study of adverse effects of high-dose intravenous (pulse) methylprednisolone therapy in patients with rheumatic disease. Annals of PharmacoTherapy 26(3): 316-320, 1992

Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapy. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 11(5): 377-379, 1988

Oral low-dose glucocorticosteroids as compared with intravenous methylprednisolone pulses in the treatment of rheumatoid arthritis. Rheumatology 38(12): 1304-1305, 1999

Oral prednisone versus intravenous methylprednisolone in hospitalized pediatric patients with acute reactive airway disease. Journal of Allergy & Clinical Immunology 99(1 PART 2): S402, 1997

Intravenous therapy with methylprednisolone and cyclophosphamide in vasculitis of peripheral nervous system. Evaluation of 8 patients. Arquivos de Neuro-Psiquiatria 56(2): 274-280, 1998

Pharmacokinetics of intravenous methylprednisolone and oral prednisone in paediatric patients with inflammatory bowel disease during the acute phase and in remission. European Journal of Clinical Pharmacology 54(7): 555-560, Sept, 1998

Comparison of an intravenous pulse of methylprednisolone versus oral corticosteroid in severe acute rheumatic carditis: a randomized clinical trial. Cardiology in the Young 12(2): 119-124, 2002

Study of the clinical and biochemical effects of 16-methylprednisolone in active rheumatic disease. Hospital 69(4): 749-778, 1966

A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide. Clinical Rheumatology 30(5): 607-614, 2011